CYTELLIGEN
Dead / Cancelled — Cancelled — Section 8 (as of 05 Jun 2024)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85892635
- Registration number
- 4436018
- Mark type
- Word mark
- Filed
- 02 Apr 2013
- Published for opposition
- 03 Sept 2013
- Registered
- 19 Nov 2013
Goods and services
- Class 005 — Pharmaceuticals: Tumor cell isolation kit comprised of diagnostic medical reagents, namely, tumor cell isolation solution and tumor marker recognizing reagent for humans and animals to detect early tumor cells in blood or body fluid
Owner
- Cytelligen Inc., San Diego, CA, US
- Cytelligen Inc., San Diego, CA, US
- Cytelligen Inc., San Diego, CA, US
Prosecution history
- 05 Jun 2024 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 19 Nov 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 18 Oct 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 18 Oct 2019 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Oct 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Sept 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Sept 2019 — TEAS SECTION 8 & 15 RECEIVED
- 19 Nov 2018 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Nov 2013 — REGISTERED-PRINCIPAL REGISTER
- 03 Sept 2013 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Sept 2013 — PUBLISHED FOR OPPOSITION
- 14 Aug 2013 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Aug 2013 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 01 Aug 2013 — ASSIGNED TO LIE
- 16 Jul 2013 — APPROVED FOR PUB - PRINCIPAL REGISTER